Uphat News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Uphat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Uphat Today - Breaking & Trending Today
this morning. welcome back to the fourth hour of morning joe. it s 9:00 a.m. in theeast, 6:00 a.m. out west. elise jordan and jonathan lemire still with us. we have a lot to get to this hour, including more on that critical inflation report just released that shows consumer prices rose less than expected last month. yay, inflation only at 8.5%. wait a second that s sti a lot. it is lower tha expected. fuel prices droppg as quickly as they have probably helped. also we have the latest development on the justice department s investigation of donald trump, this as the 45th president will be questioned under oath today in the new york attorney general s civil investigation into his real estate dealings. release the warrant, mr. president. if you care about transparency, release the warrant. you have it. let us see it. stop playing your followers as dupes. you know, doj needs to be as transparent as they can be while being fair to this possible criminal. we don t kno ....
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price shot up 11.8% during mid-day trading on Monday . The company traded as high as $11.23 and last traded at $11.22. 489,633 shares were traded during trading, a decline of 40% from the average session volume of 809,964 shares. The stock had previously closed at […] ....
Stifel Nicolaus initiated coverage on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $24.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $26.00 price objective on shares of Phathom […] ....
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […] ....
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) will release its earnings data before the market opens on Thursday, May 9th. Analysts expect Phathom Pharmaceuticals to post earnings of ($1.13) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Phathom Pharmaceuticals (NASDAQ:PHAT – Get […] ....